BackgroundKampo medicine, the traditional Japanese system of herbal medicine, is widely integrated into contemporary medical practice in Japan. However, comprehensive evaluations of long-term prescribing patterns across multiple Kampo formulations remain limited.ObjectivesTo characterize utilization patterns of major Kampo medicines in a Japanese tertiary-care hospital using prescription- and patient-level data collected over 21 years.Materials and methodsWe conducted a retrospective database study of all Kampo prescriptions issued at a Japanese university hospital between April 2001 and March 2022. Prescription-based analyses examined prescription numbers, total prescription days, and cumulative prescribed amounts. Patient-based analyses evaluated treated patients, age, sex, initial prescribing department, inpatient status at first prescription, and prescription-to-patient ratios.ResultsKampo medicines accounted for 288,815 prescriptions (1.7% of all prescriptions) and were prescribed to 57,634 patients (4.4% of all patients). Daikenchuto ranked first in patient numbers, prescriptions, total prescription days, and cumulative prescribed amounts. Distinct prescribing patterns were observed among formulations. Based on prescription-to-patient ratios, demographics, and clinical settings, major Kampo medicines were classified into four groups: acute symptomatic medicines (Kakkonto, Bakumondoto, and Shoseiryuto), chronic management medicines (Hochuekkito, Rikkunshito, Yokukansan, and Goshajinkigan), inpatient/perioperative medicines (Daikenchuto and Shakuyakukanzoto), and women’s health medicines (Tokishakuyakusan and Kamishoyosan). Daikenchuto showed a particularly high rate of inpatient initiation.ConclusionsThis 21-year real-world analysis identified distinct functional prescribing patterns among major Kampo medicines and provides a comprehensive overview of Kampo utilization in contemporary Japanese hospital practice.